Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Finished Goods: 2023-2025

Historic Finished Goods for SRx Health Solutions (SRXH) over the last 3 years, with FY2025 value amounting to $1.5 million.

  • SRx Health Solutions' Finished Goods fell 5440.78% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 5440.78%. This contributed to the annual value of $1.5 million for FY2025, which is N/A changed from last year.
  • As of FY2025, SRx Health Solutions' Finished Goods stood at $1.5 million.
  • SRx Health Solutions' 5-year Finished Goods high stood at $5.5 million for FY2023, and its period low was $1.5 million during FY2025.
  • For the 3-year period, SRx Health Solutions' Finished Goods averaged around $3.4 million, with its median value being $3.1 million (2024).
  • Examining YoY changes over the last 5 years, SRx Health Solutions' Finished Goods showed a top increase of 4354.31% in 2024 and a maximum decrease of 4354.31% in 2024.
  • Over the past 3 years, SRx Health Solutions' Finished Goods (Annual) stood at $5.5 million in 2023, then plummeted by 43.54% to $3.1 million in 2024, then tumbled by 50.52% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in FY2025, $3.1 million for FY2024, and $5.5 million during FY2023.